PHARMA LIGHT

International Pharmaceutical Business, Technology, FDA Rules and Regulations, MHRA and other News for Indian Pharmacists, Pharmaceutical Companies.

Pages

Home
PHARMA NEWS
PHARMA ACQUISITIONS
CLINICAL TRIALS
FDA APPROVAL DRUGS
SITEMAP
CONTACT US

Search This Blog

Showing posts with label International Pharmaceutical Exhibition. Show all posts

Showing posts with label International Pharmaceutical Exhibition. Show all posts

INTERNATIONAL PHARMACEUTICAL EXHIBITION INDIA 2016

Email This BlogThis!Share to X Share to Facebook Share to Pinterest

Labels: India Pharma 2016, International Pharmaceutical Exhibition

Older Posts Home

View mobile version

Subscribe to: Posts (Atom)

Featured Post

Aurobindo Pharma gains on USFDA nod for Naproxen Sodium Tablets

Aurobindo Pharma has received final approval from the US Food & Drug Administration to manufacture and market Naproxen Sodium ...

Popular Posts

Indoco Remedies get US FDA nod for its Plant

Indoco Remedies has rallied 19% to Rs 314 on the National Stock Exchange (NSE) after the company received US Food and Drug Administ...
Chugai receives Orphan Drug Designation for Tocilizumab

Chugai Pharmaceutical Co announced that it received from the Minister of Health, Labour and Welfare, a notification of orphan drug desi...
SANOFI AND REGENERON STRONGLY DISAGREE IN ONGOING PATENT LITIGATION REGARDING PRALUENT

Sanofi and Regeneron Pharmaceuticals, Inc. announced today that the companies strongly disagree with a U.S. District Court jury v...
Amgen And UCB Announce Positive Top-Line Results From Phase 3 Study Evaluating Romosozumab In Men With Osteoporosis

Amgen and UCB announced positive top-line results for romosozumab from the pivotal Phase 3 place B o-cont R olled study evaluat I ng ...
Bayer Receives FDA Approval for Kovaltry

Bayer Receives FDA Approval for Kovaltry® for the Treatment of Children and Adults with Hemophilia A The U.S. Food and Drug Admin...
Bharat Biotech develops Zika vaccine

Bharat Biotech, a Hyderabad-based vaccines and bio-therapeutic manufacturer, claimed to have achieved a breakthrough in developing a vaccin...
Reasons for Daraprim still costs USD 750 a pill

Since the news that Turing Pharmaceuticals had jacked up the price of the drug Daraprim by 5,000% broke in September, former CEO Martin S...
GSK and Adaptimmune Expand Collaboration

GlaxoSmithKline plc and Adaptimmune Therapeutics plc announced that the companies have expanded the terms of their strategic collaboratio...
U.S. and European Regulators Accept Venetoclax for Chronic Lymphocytic Leukemia

AbbVie announced that the U.S. Food and Drug Administration (FDA) accepted AbbVie's New Drug Application (NDA) granting priority revi...
Merck Acquires IOmet Pharma

Merck announced that it has acquired IOmet, a privately-held UK-based drug discovery company focused on the development of innovativ...

Total Pageviews

Labels

NEWS Clinical Trial Result USFDA Approval drugs COLLABORATION Acquisition AstraZeneca PFIZER MERCK NOVARTIS Roche SANOFI AbbVie amgen PHARMACIST JOBS TEVA allergan BOEHRINGER INGELHEIM Diabetes GSK KEYTRUDA Non Small Cell Lung Cancer multiple myeloma Eisai Eli Lilly takeda Pharma ANDA Cosentyx GlaxoSmithKline Grifols HCV HIV Novo Nordisk PATENT CHALLENGE Patent Litigation sun pharma ABBOTT AQUESYS Inc Alecensa Amgen Inc Aspen Pharmacare Holdings Ltd AstraZeneca news Avelumab BAYER BMS Baxter International News Breo Ellipta CHMP approval Cotellic DARATUMUMAB Daiichi Sankyo Daraprim Dr Reddys Drug Inspector Answers Entresto FDA Clearance Fycompa Glenmark Gout treatment Hepatitis C Janssen Johnson and Johnson Jubilant Life Science Martin Shkreli Merck KGaA Multiple Sclerosis Mylan NOVONORDISK PATENTS Perampanel Perrigo Company Pharmacy MCQs Pharmacy Sample Questions Psoriatic arthritis Purdue Pharma Repatha SANDOZ Sanofi Pasteur Stada Pharma TOFACITINIB ViiV HealthCare Zelboraf ankylosing spondylitis chronic lymphocytic leukemia chugai Pharma secukinumab venetoclax AIDS AIDS MEDICINE ALK Inhibitor AMPA receptor antagonist ANTIOBIOTICS use APREPITANT Abilify Acadia Pharma Acute Migrain Medicine Adaptive Biotechnologies Advanced Myeloma Afinitor Aflibercept Alexion Pharmaceuticals AnaBios Phase X Technology Answers Aplastic anemia Arrahona Optimus Assurant Inc Aurobindo Pharma Awards BI 1482694 BLINCYTO Basaglar Bendamustine Benlysta Bharat Biotech BioNTech BioQ Pharma Biocon BiosYnth Biosense Webster Blood diseases Breast Cancer Bristol Myers Squibb Bronchospasm Bydureon Byetta CHOLESTEROL Decrease CLIA COBAS 4800 COBAS LIAT SYSTEM Cabotegravir Cardioxyl Pharma Cariprazine Cediranib Cefazolin Celgene corporation Charles Pfizer Chronic Obstructive Pulmonary Disease Cipla Coherex Medical ComHIP Copaxone Cour Pharma Crohn's disease Cubicin Cyclopharm DATING Apps Daewoong Pharmaceuticals Dementia Discovery Fund Dengue vaccine in India Dengvaxia DiaResQ Ductal adenocarcinoma Dulaglutide Durvalumab Dyax Corp EMA EMEND ETELCALCETIDE EU Approval Eliquis Emcure Pharma Enbrel Entocort Epidermal growth factor receptor Etanercept Eumycetoma European Commission European Investment Bank European Union Evofosfamide Exviera FARYDAK FDA Alerts FDA Approved Plants FDA Orphan Drugs FDA Warning FDI in pharma FIND FluMist Forxiga Fresenius Kabi GBR 1302 Gardasil 9 Gazyva Gazyvaro GeNeuro SA Generic medicine Ghana Glatiramer acetate Glucophage XR HIV Medicine HPV Vaccine HYPERPARATHYROIDISM Hanmi Pharmaceutical Harrisvaccines Hatchtech HbA1c Head Lice Heart Failure Heart attack Hepato cellular cancer Humulin Huntington disease Hypertension Hysingla ER IBM Watson Health IMiD IOmet IPO offers Imlygic Imnovid Incyte Corporation India Bulk Drug Industry India Pharma 2016 Indian Pharma companies Indoco Remedies Infant Nutrition Institut Pasteur International Diabetes Federation International Pharmaceutical Exhibition Ketosteril Research Award Kovaltry Kremers Urban Kwikpen Kyprolis Kythera Biopharmaceuticals LESINURAD LUPIN Lapatinib Leuplin PRO Liaoning Tianyi Biologicals Linaclotide Linezolid Tablets Liraglutide MD Anderson Cancer Center MIT Medicine Menarini Mencevax Meningococcal Merck Serono Metastatic breast cancer Metastatic melanoma Metformin Mitsubishi tanabe pharma Monoclonal antibodies Mucinex Myopic choroidal neovascularization NDA NEUPOGEN biosimilar NOVAVAX Naproxen Nasopharyngeal Carcinoma Neglected diseases Nimenrix Novartis AG Novartis Foundation Novira Therapeutics NovoRapid Nucala OFEV Ofatumumab Onglyza Orchid Pharma Osimertinib Otsuka Pharma PHARMEXCIL PICS League PILL PRALUENT Pakinson PanTheryx Papilloma virus Paroxetine Tablets Pfizer RxPathway Program Pharma Entrepreneurs Pharmaceutical Business Pharmaceutical Set up Pneumonia Vaccine Pomalyst ProAir RespiClick Proximagen Ltd REVOLADE Rasagiline Regeneron Pharmaceuticals Reliqua Relvar Revlimid Rheumatoid Arthritis Rilpivirine Ryzodeg SECTION 2 SUVEN LIFE SCIENCES Sayana Press Schizophrenia Self Injectable Contraceptive Semaglutide Serbian Hemofarm AD Shire Plc Soluble guanylate cyclase Strides Study of Cirrhosis Sulfonylurea Synergetics USA Inc TEFLARO TENDYNE Holdings Inc TERMINOLOGY Tagrisso Technegas Tolerizing Immune Modifying nanoParticle Transasia BioMedicals Transgene Biotek Tresiba Tri-Lo-Marzia Trulicity Tuberculosis Turing Pharmaceuticals Tykerb Type 2 Diabetes UCB US Federal Trade Commission Upsher-Smith Lab VEIKIRAX VIEKIRA PAK VIEKIRAX Vaccine Valeant Pharma Vannier VaxYnethic Victoza Voluntis WHO antibiotic strategy Warp Drive Bio WaveCrest LAA Weizmann Institute of Science Wockhardt XEGLYZE Lotion Xeljanz ZARXIO ZARZIO ZURAMPIC Zika Vaccine Zika virus Zoetis Zydelig Zydus Zyvox adenocarcinoma alectinib anti tumor antiepileptic drug antipsychotic drugs aripiprazole auto immune diseases bacterial skin infections baricitinib brain cancer brilinta cancer cancer immunotherapy carfilzomib chronic heart failure colorectal cancer fund growth gilead sciences glioblastoma hypoglycaemia ibrutinib idelalisib idiopathic pulmonary fibrosis infliximab influenza vaccines injectable polio vaccine irritable bowel syndrome leading healthcare innovations melanoma metastatic gastric cancer olaparib ovarian cancer pembrolizumab premenopausal breast cancer prevent pregnancy remicad rituximab skin infections soft tissue sarcoma spreading STDs statin therapy sun life financial Inc syncytial virus systemic Lupus erythematosus talimogene aherparepvec talimogene laherparepvec transdermal patch velefarm holding vericiguat vraylar

counter for blogspot

Simple theme. Powered by Blogger.